Douleurs neuropathiques - Publications Scientifiques

Dernière publication 05/02/2025

Characterization of a rat model of bortezomib-induced painful neuropathy

Background and Purpose Bortezomib (Velcade®) is a breakthrough treatment for multiple myeloma, significantly improving patient survival. However,...

Array
(
    [id_prestablog_news] => 10167
    [id_shop] => 1
    [date] => 2025-02-05 20:03:33
    [date_modification] => 2025-02-05 19:15:46
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 
    [featured] => 0
    [prim_key] => 3677
    [id_lang] => 2
    [title] => Characterization of a rat model of bortezomib-induced painful neuropathy
    [paragraph] => Characterization of a rat model of bortezomib-induced painful neuropathy
    [content] => 
Authors
Natalie A Duggett, Sarah J L Flatters

Lab
Wolfson Centre for Age-Related Diseases, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
Journal
British Journal of Pharmacology
Abstract
Background and Purpose 

Bortezomib (Velcade®) is a breakthrough treatment for multiple myeloma, significantly improving patient survival. However, its use is limited by painful neuropathy often resulting in dose reduction/cessation of first-line treatment due to lack of treatment. The aim of this study was to characterize a clinically relevant rat model of bortezomib-induced painful neuropathy, using established evoked measures and novel ethological techniques, to aid drug discovery. 

Experimental Approach 

Adult male Sprague–Dawley rats were injected i.p. with 0.1 and 0.2 mg·kg−1 bortezomib, or its vehicle, on days 0, 3, 7 and 10. Multiple behavioural approaches were utilized: mechanical hypersensitivity, cold allodynia, heat hypersensitivity, motor co-ordination, burrowing and voluntary wheel running. At maximal bortezomib-induced mechanical hypersensitivity, 200 mg·kg−1 ethosuximide/vehicle and 100 mg·kg−1 phenyl N-tert-butylnitrone (PBN)/vehicle were administered i.p. in separate experiments, and mechanical hypersensitivity assessed 1, 3 and 24 h later. 

Key Results 

Bortezomib induced dose-related mechanical hypersensitivity for up to 80 days. Bortezomib induced short-term cold allodynia, but no significant change in heat hypersensitivity, motor co-ordination, voluntary wheel running and burrowing behaviour compared to vehicle-treated controls. Systemic PBN and ethosuximide significantly ameliorated bortezomib-induced mechanical hypersensitivity. 

Conclusions and Implications 

These data characterize a reproducible rat model of clinical-grade bortezomib-induced neuropathy demonstrating long-lasting pain behaviours to evoked stimuli. Inhibition by ethosuximide and PBN suggests involvement of calcium and/or ROS in bortezomib-induced painful neuropathy. These drugs could be used as preclinical positive controls to assess novel analgesics. As ethosuximide is widely used clinically, translation to the clinic to treat bortezomib-induced painful neuropathy may be possible.
    [meta_description] => 
    [meta_keywords] => 
    [meta_title] => 
    [link_rewrite] => characterization-of-a-rat-model-of-bortezomib-induced-painful-neuropathy
    [actif_langue] => 1
    [read] => 306
    [count_comments] => 0
    [id] => 10167
    [categories] => Array
        (
            [10] => Array
                (
                    [id_prestablog_categorie] => 10
                    [title] => Douleur
                    [link_rewrite] => Douleur
                )

            [29] => Array
                (
                    [id_prestablog_categorie] => 29
                    [title] => Douleurs neuropathiques
                    [link_rewrite] => Douleurs-neuropathiques
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => Characterization of a rat model of bortezomib-induced painful neuropathy
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [40] => Array
                (
                    [name] => Roues Instrumentées Premium pour Exercice Spontané
                    [description_short] => 
La roue d'activité spontanée BIOSEB offre une solution efficace pour quantifier l'activité volontaire des rongeurs dans leur cage d'hébergement. Le boitier embarqué permet d'enregistrer une large gamme de mesures, notamment le nombre de révolutions de la roue, la vitesse moyenne/minimale/maximale, l'accélération, le temps d'utilisation, les événements d'accès, ...etc. 
Le modèle Premium enrichit ces fonctionnalités standards en permettant à l'utilisateur de filmer les animaux et augmenter la complexité des tâches grâce au retrait des barreaux. Au-delà des maladies neuromusculaires, cet outil facilite également l'étude des troubles neurodégénératifs, tels que la maladie de Parkinson, la maladie de Huntington et la SLA (sclérose latérale amyotrophique).

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/preprod.bioseb.com/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://preprod.bioseb.com/fr/activite-systeme-moteur-coordination/40-spontaneous-activity-wheels.html
                )

            [1875] => Array
                (
                    [name] => Roues Instrumentées Basiques pour Exercice Spontané
                    [description_short] => 
La Roue Instrumentée pour Exercice Spontané est une méthode simple pour mesurer l'activité spontanée de rongeurs dans leur cage de vie - particulièrement adapté à la souris, ces roues se déclinent aussi chez le rat. L'électronique associée à un logiciel mesure la distance parcourue, la vitesse (Moy, min, max), l'accélération, le temps et le nombre d'accès à la roue. Un outil idéal pour les criblages de drogues, ainsi que les études sur le phénotypage et les maladies neuromusculaires. Chaque roue intègre un totalisateur embarqué (distances) consultable sans logiciel. Un nouveau logiciel est disponible pour contrôler jusqu'à 64 roues.

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/preprod.bioseb.com/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://preprod.bioseb.com/fr/activite-systeme-moteur-coordination/1875-spontaneous-activity-wheels.html
                )

        )

)
1